The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro1
Abstract
The morphogenesis and remodeling of bone depends on the integrated activity of osteoblasts that form bone and osteoclasts that resorb bone. We previously reported the isolation of a new cytokine termed osteoclastogenesis inhibitory factor, OCIF, which specifically inhibits osteoclast development. Here we report the cloning of a complementary DNA of human OCIF. OCIF is identical to osteoprotegerin (OPG), a soluble member of the tumor-necrosis factor receptor family that inhibits osteoclastogenesis. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number in normal rats. Osteoblasts or bone marrow-derived stromal cells support osteoclastogenesis through cell-to-cell interactions. A single class of high affinity binding sites for OPG/OCIF appears on a mouse stromal cell line, ST2, in response to 1,25-dihydroxyvitamin D3. An anti-OPG/OCIF antibody that blocks the binding abolishes the biological activity of OPG/OCIF. When the sites are blocked with OPG/OCIF, ST2 cells fail to support osteoclastogenesis. These results suggest that the sites are involved in cell-to-cell signaling between stromal cells and osteoclast progenitors and that OPG/OCIF inhibits osteoclastogenesis by interrupting the signaling through the sites.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OPG is an atypical member of the TNF receptor family in that it is a secreted protein with no transmembrane domain and no direct signaling properties (4,6).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [6]
Citations
Cites
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,736
The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
Smith, C. A., Farrah, T., & Goodwin, R. G. (1994) · Cell · doi:10.1016/0092-8674(94)90372-7 · Cited by 1,909
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B. F., Broxmeyer, H. E., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,440
Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M., & Arai, N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.466-472.1988 · Cited by 1,330
A novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,108
Modulation of Osteoclast Differentiation
Suda, T., Takahashi, N., & Martin, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 934
Cited by
Sorted by citations
Items 901–999 of 999
Owen, S., Sanders, A. J., MASON, M. D., & Jiang, W. G. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3339 · Cited by 7
Bispecific Antibody Binding To RANKL and Osteonectin with Enhanced Localization to the Bone
Chen, J.-H., Lin, C. Y., Chen, Y.-C. M., Tian, W., Chu, H., & Chang, T. W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00501 · Cited by 7
Kram, V., Jani, P. H., Kilts, T. M., Li, L., Chu, E. Y., & Young, M. F. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107627 · Cited by 7
Baud’huin, M., Charrier, C., Bougras-Cartron, G., Brion, R., Lézot, F., Padrines, M., & Heymann, D. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-498-8_21 · Cited by 7
Takahashi, N., Kobayashi, Y., & Udagawa, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00005-1 · Cited by 10
Novick, D., & Rubinstein, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-439-1_12 · Cited by 7
Zheng, F., Liang, H., Liu, R., Quan, J.-X., Li, X., Dai, C.-L., Guo, G., Zhang, J., & Wang, B. (2008) · Endocrine · doi:10.1007/s12020-008-9118-2 · Cited by 7
Amling, M., Schilling, A. F., Haberland, M., & Rueger, J. M. (2001) · Der Orthopäde · doi:10.1007/s001320170072 · Cited by 6
Serum markers of bone turnover in dialyzed patients separated according to age
Grzegorzewska, A. E., & Młot-Michalska, M. (2006) · International Urology and Nephrology · doi:10.1007/s11255-006-0079-1 · Cited by 8
The Activating Protein-1 Transcriptional Complex: Essential and Multifaceted Roles in Bone
Yamashita, J., & McCauley, L. K. (2006) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1385/bmm:4:2:107 · Cited by 7
Gonzalez-Calvin, J. L., Mundi, J. L., Casado, F. J., & Olivares, E. G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.047 · Cited by 7
Feng, G., Zhou, Y., Yan, J., Wang, Z., Yang, Y., Zhao, W., Wang, N., Lü, Z., Chen, Y., & Jin, Q. (2023) · Journal of Proteomics · doi:10.1016/j.jprot.2023.104896 · Cited by 6
Rattajak, P., Aroonkesorn, A., Smythe, C., Wititsuwannakul, R., & Pitakpornpreecha, T. (2024) · Molecules · doi:10.3390/molecules29092113 · Cited by 5
Škubica, P., Hoffmanová, I., & Daňková, P. (2025) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2025.109871 · Cited by 6
van Leeuwen, J. P. T. M., van der Eerden, B. C. J., van de Peppel, J., Stein, G. S., & Lian, J. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00009-1 · Cited by 7
Bone niche and bone metastases
Han, Y., & Kang, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00041-4 · Cited by 6
Sun, W., Xie, W., Hu, K., Yang, Z., Han, L., Li, L., Qi, Y., & Wei, Y. (2024) · Polymers · doi:10.3390/polym16040498 · Cited by 6
Contributions to osteoclast biology from Japan
Suda, T., & Takahashi, N. (2008) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.84.419 · Cited by 6
Yousuf, D., Afifi, O. H., Soudany, K. S. E., & Ghoniem, S. M. (2013) · Tanta Dental Journal · doi:10.1016/j.tdj.2013.08.003 · Cited by 6
Şen, O., Gökçel, A., Kızılkılıç, O., Erdogan, B., Aydin, M. V., Sezgin, N., Yalçin, Ö., Caner, H., & Altınörs, N. (2005) · Neurological Research · doi:10.1179/016164105x15631 · Cited by 6
OPG-RANKL Levels after Continuous Orthodontic Force
Tuncer, B. B. (2013) · Gazi Medical Journal · doi:10.12996/gmj.2013.09 · Cited by 6
Disorders of Calcium Metabolism
Heras-Herzig, A., & Guise, T. A. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50070-x · Cited by 6
Karsenty, G., & Kronenberg, H. M. (2003) · Elsevier eBooks · doi:10.1016/b978-012286551-0/50006-3 · Cited by 6
Genome-Wide Perspectives on Vitamin D Receptor–Mediated Control of Gene Expression in Target Cells
Pike, J. W., Meyer, M. B., Lee, S. M., Onal, M., & Benkusky, N. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00009-4 · Cited by 6
Bone marker gene expression in calvarial bones: different bone microenvironments
Al‐Amer, O. M. (2017) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-017-0066-y · Cited by 6
Ito, H., Kifune, T., Ishiyama, M., Iwasa, S., Takei, H., Hasegawa, T., Asano, M., & Shirakawa, T. (2018) · Journal of Oral Science · doi:10.2334/josnusd.17-0436 · Cited by 6
Lu, H. ‐., Yeh, K., Wu, M., Li, C., & Tseng, C. ‐. (2008) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2007.00415.x · Cited by 6
Bone marrow cells produce soluble factors that inhibit osteoclast activity
Ninomiya, J. T., Bi, Y., Banks, M. A., Lavish, S. A., Goldberg, V. M., & Greenfield, E. M. (1999) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100170109 · Cited by 6
Geng, T., Sun, S., Chen, X., Wang, B., Guo, H., Zhang, S., & Jin, Q. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8292 · Cited by 6
Yasuda, H. (2019) · Folia Pharmacologica Japonica · doi:10.1254/fpj.153.11 · Cited by 6
Self-citationPérez‐Amodio, S., & Engel, E. (2014) · doi:10.1002/9781118406748.ch11 · Cited by 6
Vitamin D and bone-How does vitamin D regulate bone formation and resorption?-
Suda, T. (2004) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.80.407 · Cited by 6
Rhythms in your bones: how circadian rhythms impact bone cell function and skeletal health
Görgün, C., Lordan, R., Kennedy, O. D., Hoey, D. A., & Curtis, A. M. (2026) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2026.04.008 · Cited by 5
Heart Failure and Osteoporosis: Shared Challenges in the Aging Population
Spoladore, R., Ciampi, C. M., Ossola, P., Sultana, A., Spreafico, L. P., Farina, A., & Fragasso, G. (2025) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd12020069 · Cited by 5
Miyaji, Y., Kasuya, Y., Furuta, Y., Kurihara, A., Takahashi, M., Ogawara, K., Izumi, T., Okazaki, O., & Higaki, K. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0807-4 · Cited by 5
Meneses, C. C. B., Diogenes, A. R., & Sipert, C. R. (2022) · Journal of Endodontics · doi:10.1016/j.joen.2022.09.005 · Cited by 5
Osteoprotegerin Gene as a Biomarker in the Development of Osteoporosis in Postmenopausal Women
Przerwa, F., Uzar, I., Bogacz, A., Kotrych, K., Sulikowski, T., Wolek, M., Kamiński, A., Ziętek, P., & Czerny, B. (2023) · Biomedicines · doi:10.3390/biomedicines11123218 · Cited by 5
Unraveling the Mechanisms That Regulate Osteoclast Differentiation: A Review of Current Advances
Zhang, S., Gao, M., Song, S., Zhao, T., Zhou, B.-H., Wang, H., Tian, W., Zhao, W., & Zhao, J. (2025) · genesis · doi:10.1002/dvg.70012 · Cited by 7
Heritability of Serum Osteoprotegerin
Kwan, J. S. H., Xiao, S., Bow, C., Cheung, C., Soong, C., Lau, K. S., Sham, P. C., & Kung, A. W. (2011) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2011.00661.x · Cited by 5
Denosumab for treatment of breast cancer bone metastases and beyond
Nangia, J. R., JOSEPH, D. R., Nguyen, C. M., Mendes, M., & Trivedi, M. V. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.664634 · Cited by 6
Preventing metastases to bone: Denosumab or bisphosphonates?
Nanes, M. S. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.71 · Cited by 5
Kim, J., Jang, S., Kim, A., Su, H., Gunawardhana, N., Jeon, Y., Bak, E. J., Kim, J.-H., & Cha, J. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-6137-1 · Cited by 5
Enomoto, T., Takami, M., Yamamoto, M., & Kamijo, R. (2017) · Cytotechnology · doi:10.1007/s10616-017-0094-3 · Cited by 5
Pérez‐Hernández, N., Posadas‐Sánchez, R., Vargas‐Alarcón, G., Cazarín-Santos, B. G., Miranda‐Duarte, A., & Rodrı́guez-Pérez, J. M. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5949 · Cited by 5
Vascular calcification; Stony bridge between kidney and heart
Zaker, B., & Ardalan, M. (2020) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.2020.29 · Cited by 8
Where is bone science taking us?
Langdahl, B. L., Uitterlinden, A. G., & Ralston, S. H. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101791 · Cited by 5
Matsui, H., Nakatani, Y., Yoshida, H., Takizawa, A., Takeuchi, O., Øverby, A., Takahashi, T., Murayama, S. Y., & Matsuo, K. (2016) · Cellular Microbiology · doi:10.1111/cmi.12581 · Cited by 5
Sponder, M., Campean, I., Emich, M., Fritzer‐Szekeres, M., Litschauer, B., Bergler-Klein, J. K., Graf, S., & Strametz‐Juranek, J. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0452-7 · Cited by 5
Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial Growth
Gama, A., Maman, L., Vargas-Franco, J. W., Omar, R., Royer, B. B.-L., Yagita∥, H., Babajko, S., Berdal, A., Acevedo, A. C., Heymann, D., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040898 · Cited by 5
Hamed, E. A., Mohamed, N., El‐Metwally, T. H., & Kamal, M. M. (2010) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e3181d419d6 · Cited by 5
The CD9 Molecule on Stromal Cells
Hayashi, S., Miyake, K., & Kincade, P. W. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009087017 · Cited by 5
A role for TNF in bone resorption of deciduous molars in human beings
Ureles, S. D., Chrzan, J. M., Norton, L. A., & Rossomando, E. F. (2000) · American Journal of Orthodontics and Dentofacial Orthopedics · doi:10.1067/mod.2000.105249 · Cited by 5
Margonato, A., Gorla, R., Macchi, A., Buzzetti, F., Franzoni, I., Pedrigi, M. C., Rosa, I., Sirtori, M., Villa, I., & Rubinacci, A. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328365b57d · Cited by 5
Lian, J. B., & Stein, G. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50008-2 · Cited by 5
Lian, J. B., & Stein, G. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088562-6/50015-7 · Cited by 31
Christakos, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50134-7 · Cited by 5
Tähtelä, R. (2004) · Työväentutkimus Vuosikirja · Cited by 5
Immunomodulation of Multiple Myeloma Bone Disease
Grano, M., Brunetti, G., & Colucci, S. C. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9058-2 · Cited by 4
Glucocorticoids, Inflammation, and Bone
Ng, K. W., & Martin, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_7 · Cited by 4
Jabari, E., Choe, R. H., Kuzemchak, B. C., Venable-Croft, A., Choi, J. Y., McLoughlin, S. T., Packer, J. D., & Fisher, J. P. (2024) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2024.0162 · Cited by 4
Sclerostin and OPG/RANK-L system take part in bone remodeling in patients with acromegaly
Halupczok-Żyła, J., Jawiarczyk-Przybyłowska, A., & Bolanowski, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1472680 · Cited by 5
Xiao, L.-Q., Wang, H.-T., Li, Y., Zeng, Q., Zhou, E., Ni, X., & Huan, Z.-P. (2015) · PubMed · Cited by 4
Feng, M., Liu, L., Wang, J., Zhang, J., Qu, Z., Wang, Y., & He, B. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s401519 · Cited by 4
Resolvins in Periodontitis and Possible Periodontal Regeneration: A Literature Review
Chiluveru, S., Gundelly, M., Pusuluri, S. V., Tummanepally, M., Chandaka, M., & Koduganti, R. R. (2024) · Cureus · doi:10.7759/cureus.68187 · Cited by 5
The Role of the Immune System in the Development of Osteoporosis
Mödder, U. I., Riggs, B. L., & Khosla, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10009-3 · Cited by 4
Partial rescue of B cells in microphthalmic osteopetrotic marrow by loss of response to type I IFNs
Roundy, K. M., Spangrude, G. J., Weis, J. J., & Weis, J. H. (2005) · International Immunology · doi:10.1093/intimm/dxh327 · Cited by 4
Serum chitotriosidase in postmenopausal women with severe osteoporosis
Musumeci, M., Palermo, A., D'Onofrio, L., Vadalà, G., Greto, V., Stasio, E. D., Maddaloni, E., Rosa, M. D., Tibullo, D., Silvia, A., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3254-3 · Cited by 5
Osteoclastogenesis and Vitamin D
Nakamichi, Y., Takahashi, N., Udagawa, N., & Suda, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00018-5 · Cited by 4
Safadi, F. F., & Khurana, J. S. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-355-4_1 · Cited by 5
Pandey, A. K., Chaturvedi, T. P., Pandey, B. L., & Deshpande, S. B. (2013) · Indian Journal of Dentistry · doi:10.1016/j.ijd.2013.11.006 · Cited by 4
In Vivo Expression of Classic PKC Isoforms in the Rat Dental Follicle as Related to Tooth Eruption
Yao, S., & Wise, G. E. (2004) · Connective Tissue Research · doi:10.1080/03008200490882628 · Cited by 4
Gruber, H. E., & Rude, R. K. (2003) · Biotechnic & Histochemistry · doi:10.1080/10320290310001630476 · Cited by 4
Nakano, M., Tsuboi, T., Kato, M., Kurita, K., & Togari, A. (2003) · Oral Diseases · doi:10.1034/j.1601-0825.2003.02904.x · Cited by 4
Osteoporosis Associated with Rheumatologic Disorders
Goldring, S. R. (2001) · Elsevier eBooks · doi:10.1016/b978-012470862-4/50055-6 · Cited by 4
Gene Expression Profile of Osteoblast-Like Cells on Calcium Phosphate Biomaterials
Takemura, T., Fan, H. S., Ikoma, T., Tanaka, M., & Hanagata, N. (2007) · Key engineering materials · doi:10.4028/www.scientific.net/kem.330-332.1087 · Cited by 4
RANKL (Receptor activator of NFκB ligand)
Blake, S., & JAMES, I. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50041-7 · Cited by 4
Expression and Identification of Mutated Osteoprotegerin in Culture Cells and Larvae of Silkworm
Xiao, H., Jin, Y., & Zhang, Y. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.5.331 · Cited by 4
Xiang, T., Zhou, Z., Li, Y., Suo, Y., Dai, J., Shi, X., Zhou, X., & Sheng, L. (2025) · The FASEB Journal · doi:10.1096/fj.202501626r · Cited by 3
Unraveling Jawbone Susceptibility: Distinctive Features Underlying Medication-Related Osteonecrosis
Paczona, B., Piffkò, J., & Janovszky, Á. (2026) · Dentistry Journal · doi:10.3390/dj14010018 · Cited by 3
Parathyroid hormone and parathyroid hormone–related protein actions on bone and kidney
Bisello, A., & Friedman, P. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00027-0 · Cited by 3
Effects of gallotannin on osteoclastogenesis and the p38 MAP kinase pathway
Hosoyama, Y., Domae, E., Goda, S., & Matsumoto, N. (2016) · Orthodontic Waves · doi:10.1016/j.odw.2016.10.007 · Cited by 3
Integrative modeling of drug therapy and the bone turnover
Javed, S., Sohail, A., & Nutini, A. (2018) · Clinical Biomechanics · doi:10.1016/j.clinbiomech.2018.10.019 · Cited by 3
Okamoto, K., & Takayanagi, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00016-2 · Cited by 3
The Role of Pro-Inflammatory Mediator Interleukin-32 in Osteoclast Differentiation
Nazir, T., Taha, N., Islam, A., Rabi, I., & Shah, P. A. (2022) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2022.69922 · Cited by 3
Lee, S. M., Meyer, M. B., Benkusky, N. A., & Pike, J. W. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106335 · Cited by 3
Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan
Yasuda, H. (2013) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.36.209 · Cited by 3
Self-citationWhat is the rank of RANKL in spondylarthritis?
Loddenkemper, K., & Burmester, G. R. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23289 · Cited by 3
Oral administration activity determination of recombinant osteoprotegerin from silkworm larvae
Xiao, H., Zhang, Y., & Wu, X. (2007) · Molecular Biotechnology · doi:10.1007/bf02686103 · Cited by 3
Physiological Regulation of Bone Metabolism and Estrogen Agonism
García‐Pérez, M. Á. (2006) · Springer eBooks · doi:10.1007/3-540-34742-9_7 · Cited by 3
Andjelkovic, Z., Katić, V., Mihailovic, D., Petrović, A., & Bubanovic, I. (2004) · Archive of oncology · doi:10.2298/aoo0402112a · Cited by 3
Kruger, M. C. (2015) · International Journal of Food and Nutritional Science · doi:10.15436/2377-0619.15.021 · Cited by 3
Senn, D., Schwalder, P., Roux, P., Bosshardt, D. D., & Stoffel, M. H. (2010) · Journal of Veterinary Dentistry · doi:10.1177/089875641002700201 · Cited by 3
Thomas, C., & Lamoureux, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00053-4 · Cited by 3
Oranger, A., Colaianni, G., & Grano, M. (2013) · Springer eBooks · doi:10.1007/978-88-470-5483-7_1 · Cited by 3
Molecules Regulating Macrophage Fusions
Miyamoto, T. K., & Suda, T. (2010) · Springer eBooks · doi:10.1007/978-90-481-9772-9_11 · Cited by 3
Aubin, J. E., & Heersche, J. N. M. (2003) · Elsevier eBooks · doi:10.1016/b978-012286551-0/50004-x · Cited by 5
Targeting Lymphoma Cells and Their Microenvironment with Novel Antibodies
Wedgwood, A., & Younes, A. (2006) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2006.s.006 · Cited by 3
Jelaska (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200010)43:10 · Cited by 2
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Metadata
- Authors
- Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., & Higashio, K.
- Affiliations
- Megmilk Snow Brand (Japan) (JP)
- Corresponding author
- Higashio, Kanji
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1998-03
- Volume
- 139
- Issue
- 3
- Pages
- 1329-1337
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2167886526
- Cited by
- 1,201
- References
- 33
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 21 · 2023: 15 · 2022: 21 · 2021: 21 · 2020: 29 · 2019: 36 · 2018: 22 · 2017: 38 · 2016: 22 · 2015: 28 · 2014: 36 · 2013: 54 · 2012: 35
- FWCI
- 24.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- osteoprotegerin, osteoclastogenesis inhibition, TNF receptor superfamily, bone remodeling, bone mineral density, stromal cells, osteoblasts, cell-to-cell signaling, 1,25-dihydroxyvitamin D3, bone resorption, gene cloning
- MeSH terms
- Amino Acid Sequence, Animals, Cells, Cultured, Cloning, Molecular, Glycoproteins, Humans, Male, Molecular Sequence Data, Osteoclasts, Recombinant Proteins, Bone Density, Bone Remodeling, Rats, Sprague-Dawley, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Mice, Rats, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review